2 results
Approved WMOCompleted
Aim of the present study is to assess normal values of EGJ distensibility in healthy volunteers.
Approved WMOCompleted
Currently, caplacizumab is being developed for treatment of acquired thrombotic thrombocytopenic purpura (TTP). TTP is a rare and potentially life-threatening thrombotic microangiopathy, in which accumulation of ULvWF multimers leads to an increased…